11 completed, 5 unknown, 3 withdrawn, 2 recruiting. 4 Phase 3, 3 Not applicable, 3 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Completed 1, Withdrawn 1 |
| Not applicable | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Choroiditis: new trials by email Literature Review of Choroiditis trials Research Report on Choroiditis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quantification & Classification of Inflammatory Cells in Uveitis Using OCT Anterior Uveitis (AU), Birdshot Chorioretinitis | Recruiting | Oregon Health and Science University | 125 | 2024-09-01 | 2025-07-17 | |
| Pregnancy and Congenital Toxoplasmosis Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis | Completed | Hospices Civils de Lyon | 76 | 2023-05-10 | 2026-01-22 | |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis | Completed | TScan Therapeutics, Inc. | 238 | 2023-01-03 | 2026-09-15 | |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Ocular Changes in Vitiligo Patients on Therapy Optical coherence tomography angiography (OCT-A) - Vitiligo, Chorioretinopathy | Unknown | Benha University | 100 | 2022-03-10 | 2022-04-19 | |
| SD-OCT Guided Treatment of Fungal Chorioretinitis Fluconazole 150 mg - Fungal Retinitis | Unknown | Benha University | 10 | 2020-01-15 | 2021-12-15 | |
| Six-months Versus Nine-months ATT for Ocular TB Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis | Phase 4 | Completed | L.V. Prasad Eye Institute | 58 | 2020-01-01 | 2024-09-26 |
| Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis Bevacizumab - Punctate Inner Choroidopathy | Completed | Changhua Christian Hospital | 14 | 2018-10-01 | 2019-04-01 | |
| Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis Intravitreal injection, Fluorescent angiography, Visometry - Chorioretinitis | Not applicable | Unknown | The Filatov Institute of Eye Diseases and Tissue Therapy | 100 | 2018-03-27 | 2021-02-03 |
| Ocular Manifestations in Rheumatic Diseases No intervention used - Uveitis, Conjunctivitis | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 5000 | 2013-05-01 | 2022-04-12 | |
| Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Trimethoprim-Sulfamethoxazole - Ocular Toxoplasmosis | Phase 3 | Completed | University of Campinas, Brazil | 141 | 2011-10-01 | 2016-07-12 |
| Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Bevacizumab (Avastin; Genentech, Inc.), Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy - Choroidal Neovascularization, Myopia | Not applicable | Withdrawn | Massachusetts Eye and Ear Infirmary | 2010-08-01 | 2014-01-14 | |
| Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes. Hearing Loss, Mental Retardation | Withdrawn | Oslo University Hospital | 2010-08-01 | 2022-09-23 | ||
| Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Fluorescein angiography, Dilated fundus examination, Toxoplasmosis serology - Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection | Not applicable | Completed | University Hospital, Grenoble | 72 | 2010-01-01 | 2016-07-25 |
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
| Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 58 | 2007-09-01 | 2013-01-23 |
| Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Bevacizumab, Intravitreal Injection of Bevacizumab - Vogt Koyanagi Harada Disease, Serpiginous Choroiditis | Phase 3 | Withdrawn | Asociación para Evitar la Ceguera en México | 2006-12-01 | 2024-05-30 | |
| To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis pyrimethamine-sulfadiazine + prednisolone, Clindamycin+Dexamethasone - Chorioretinitis | Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 2005-07-01 | 2008-07-30 | |
| Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD) Observational study - Birdshot Chorioretinopathy, Posterior Uveitis | Recruiting | Assistance Publique - Hôpitaux de Paris | 600 | 2004-11-02 | 2026-03-04 | |
| Evaluation and Treatment of Patients With Inflammatory Eye Diseases Choroiditis, Iridocyclitis | Completed | National Eye Institute (NEI) | 300 | 2000-08-19 | 2017-07-02 |
Showing 20 of 21. Sign in to see all of them.
Chorioretinitis (9) · Uveitis (7) · Birdshot Chorioretinopathy (5) · Macular Edema (5) · Multifocal Choroiditis (4) · Behcet Syndrome (3) · Sarcoidosis (3) · White Dot Syndromes (3) · Central Serous Chorioretinopathy (2) · Choroidal Neovascularization (2) · Iridocyclitis (2) · Pars Planitis (2) · Retinal Vasculitis (2) · Toxoplasmosis (2)
Choroid Diseases (21) · Eye Diseases (21) · Uveal Diseases (21) · Panuveitis (20) · Uveitis, Posterior (19) · Retinal Diseases (18) · Uveitis (14) · Retinitis (13) · Immune System Diseases (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Autoimmune Diseases (5) · Cardiovascular Diseases (5) · Chorioretinitis (5) · Infections (5)
Bevacizumab (3) · Dexamethasone (1) · Fluconazole (1) · Fluorescein Angiography (1) · Interferon alpha-2 (1) · Intravitreal Injections (1) · Observation (1) · Ophthalmoscopy (1) · Postpartum Period (1) · Prednisolone (1) · Prednisone (1) · Punctures (1) · Slit Lamp Microscopy (1) · Sulfamethoxazole (1) · Triamcinolone Acetonide (1)
Benha University (3) · Assistance Publique - Hôpitaux de Paris (2) · National Eye Institute (NEI) (2) · Asociación para Evitar la Ceguera en México (1) · Changhua Christian Hospital (1) · Hospices Civils de Lyon (1) · L.V. Prasad Eye Institute (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Massachusetts Eye and Ear Infirmary (1) · Novartis Pharmaceuticals (1) · Oregon Health and Science University (1) · Oslo University Hospital (1) · Shahid Beheshti University of Medical Sciences (1) · TScan Therapeutics, Inc. (1) · The Filatov Institute of Eye Diseases and Tissue Therapy (1)
United States (5) · France (4) · Egypt (2) · Brazil (1) · Burma (1) · Germany (1) · India (1) · Iran (1) · Mexico (1) · Norway (1) · Taiwan (1) · Thailand (1) · Ukraine (1) · United Arab Emirates (1)
Ahmed A Abdelshafy, MD (1) · Amal A Yousif, MD (1) · Andrii MD Korol, PhD (1) · Ivana K Kim, MD (1) · Janet Pope, MD (1) · Laurence Bouillet, Professor (1) · LuzElena Concha-Del Rio, MD (1) · Martine Wallon (1) · Masoud Soheilian, MD (1) · Rodrigo PC Lira, PhD (1)
PMID 12095806, PMID 15079763, PMID 20926833, PMID 25638011, PMID 37204866, PMID 39250617, PMID 40010761, PMID 40522203
R21EY036563 (1)